Hanmi Pharmaceutical founder and chairman Lim Sung-ki will transfer his company shares, worth 110 billion won, as gifts to Hanmi Pharmaceutical employees.
“Chairman Lim has decided to give away approximately 900,000 shares of Hanmi Science to nearly 2,800 employees,” said Hanmi Pharmaceutical Group on Jan.4.
Accordingly, each of the employees will be given shares amounting to 1000 percent of his or her monthly pay.
Chairman Lim encouraged his employees by saying: “For the past five years, Hanmi Pharmaceutical has strived to weather crises such as rapid changes in the business environment and across-the-board price cuts for drugs. In the face of deficits and a salary freeze, Hanmi Pharmaceutical has continued to make R&D investments.”
Last year, Hanmi Pharmaceutical clinched a total of seven mega license agreements (worth 8 trillion won) with global drugmakers, including Eli Lilly, Boehringer Ingelheim, Sanofi and Janssen.
